Sudo Biosciences
Latest round
- Series B
Last raised
- Dec 2023
Total raised
- $101M
Investors
- 11
About Sudo Biosciences
, also known as Sudo, is a biopharmaceutical company that engages in the development and commercialization of novel drugs for the treatment of immune-mediated inflammatory conditions. The company also has offices in Indianapolis (IN) and London (UK). In January 2024, Sudo Biosciences, Inc.’s product pipeline includes TYK2 (tyrosine kinase 2) inhibitors, a novel anti-inflammatory therapeutic that can be used for treating various medical conditions such as psoriasis, psoriatic arthritis, and lupus by inhibiting TYK2 pseudokinase genes. In addition, the company’s drugs could also be used for the treatment of autoimmune disorders such as ankylosing spondylitis, ulcerative colitis, multiple sclerosis, Crohn’s disease, etc.
Who invested in Sudo Biosciences
11 investors across 3 rounds
See all investors in Sudo Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Sudo Biosciences
Who invested in Sudo Biosciences?
Sudo Biosciences has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sudo Biosciences raised?
Sudo Biosciences has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Sudo Biosciences last raise money?
Sudo Biosciences's most recent round on record is a Series B, in Dec 2023.
What does Sudo Biosciences do?
, also known as Sudo, is a biopharmaceutical company that engages in the development and commercialization of novel drugs for the treatment of immune-mediated inflammatory conditions.
Where is Sudo Biosciences headquartered?
Sudo Biosciences is headquartered in Carmel, US.
Which VCs invest in companies like Sudo Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Sudo Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Sudo Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.